×
For best experience we recommend to activate Javascript in your browser.
AFAP1L2 antibody (AA 355-485)
This Rabbit Polyclonal antibody specifically detects AFAP1L2 in WB, ELISA and IHC. It exhibits reactivity toward Human.
Catalog No. ABIN7567907
$302.55
$355.94
save $53.39 (-15 %)
Plus shipping costs $50.00
Delivery in 12 to 14 Business Days
Quick Overview for AFAP1L2 antibody (AA 355-485) (ABIN7567907)
Target
See all AFAP1L2 Antibodies
AFAP1L2
(Actin Filament Associated Protein 1-Like 2 (AFAP1L2))
Reactivity
All reactivities for AFAP1L2 antibodies
Human
Host
All hosts for AFAP1L2 antibodies
Rabbit
Clonality
All clonalities for AFAP1L2 antibodies
Polyclonal
Conjugate
All conjugates for AFAP1L2 antibodies
This AFAP1L2 antibody is un-conjugated
Application
All applications for AFAP1L2 antibodies
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)
Product Details anti-AFAP1L2 Antibody
(hide)
Binding Specificity
All epitopes for AFAP1L2 antibodies
AA 355-485
Purpose
Anti-Human AFAP1L2 Polyclonal Antibody
Purification
Antigen affinity purification.
Immunogen
E. coli - derived recombinant Human AFAP1L2 (Glu355-Glu485).
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
0.01M PBS, pH 7.4, 50 % glycerol, 0.05 % Proclin 300.
Preservative
ProClin
Precaution of Use
This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C,-80 °C
Storage Comment
Use a manual defrost freezer and avoid repeated freeze thaw cycles.Store at 4°C for frequent use.Store at -20 to -80 °C for twelve months from the date of receipt.
Target Details for AFAP1L2
(hide)
Target
AFAP1L2
(Actin Filament Associated Protein 1-Like 2 (AFAP1L2))
Alternative Name
AFAP1L2
Background
KIAA1914, AFAP1-like protein 2, Actin filament-associated protein 1-like 2, AFAP1L2, XB130
UniProt
Q8N4X5
Pathways
EGFR Signaling Pathway
Recently viewed
(hide)
Chat with us , powered by LiveChat